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ABSTRACT 
The mammalian target of rapamycin (mTOR) is a key regulator of cellular growth that 
associates with other proteins to two multi-protein complexes, called mTORC1 and 
mTORC2. Dysregulation of mTORC1 signalling in brain is implicated in neuropathological 
conditions, such as autism spectrum or neurodegenerative disorders. Accordingly, allosteric 
mTOR inhibitors are currently in clinical trials for the treatment of such disorders. Here, we 
ablated either mTORC1 or mTORC2 conditionally in Purkinje cells of the mouse cerebellum 
to dissect their role in the development, function and survival of these neurons. We find that 
the two mouse models largely differ from each other by phenotype and cellular responses. 
Inactivation of mTORC2, but not of mTORC1, led to motor coordination deficits at an early 
age. This phenotype correlated with developmental deficits in climbing fibre elimination and 
impaired dendritic self-avoidance in mTORC2-deficient Purkinje cells. In contrast, 
inactivation of mTORC1, but not of mTORC2, affected social interest of the mice and caused 
a progressive loss of Purkinje cells due to apoptosis. This cell loss was paralleled by age-
dependent motor deficits. Comparison of mTORC1-deficient Purkinje cells with those 
deficient for the mTORC1 inhibitor TSC1 revealed a striking overlap in Purkinje cell 
degeneration and death, which included neurofilamentopathy and reactive gliosis. Altogether, 
our study reveals distinct roles of mTORC1 and mTORC2 in Purkinje cells for mouse 
behaviour and the survival of neurons. Our study also highlights a convergence between the 
phenotypes of Purkinje cells lacking mTORC1 activity and those expressing constitutively 
active mTORC1 due to TSC1 deficiency.   
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INTRODUCTION  
In mammalian cells, the serine/threonine protein kinase mTOR assembles into two multi-
protein complexes, called mTORC1 and mTORC2. The two complexes share some proteins 
but differ for others. For example, raptor selectively associates with mTORC1 and is required 
for its function whereas rictor is only found in mTORC2 and is essential for its function 
(Laplante & Sabatini, 2012). mTORC1 controls cell growth and proliferation and integrates 
various signals from growth factors, energy status or amino acid availability and as output 
promotes protein synthesis, contributes to lipogenesis and inhibits autophagy (Shimobayashi 
& Hall, 2014). Growth factor signals converge on, and inhibit, the tuberous sclerosis complex 
(TSC), which is an upstream inhibitor of mTORC1. In contrast to mTORC1, activation of 
mTORC2 is less well understood, but it is well established that this complex phosphorylates 
and activates members of the AGC kinase family, including Akt, SGK1 and PKCs, which 
ascribes this complex a role in cell survival, metabolism and actin cytoskeletal organization 
(Oh & Jacinto, 2011). Ablation of raptor in the brain results in perinatal death of mice 
(Cloetta et al., 2013). In contrast, whole-brain rictor knockout mice are viable but ataxic and 
they show a strong Purkinje cell phenotype (Thomanetz et al., 2013). Recent reports have also 
shown that increased activation of mTORC1 in mouse Purkinje cells by conditional deletion 
of Tsc1 or Tsc2 or loss of one allele causes an autistic-like behaviour (Tsai et al., 2012; Reith 
et al., 2013). Concordantly, human patients suffering from the TSC disorder caused by 
mutations in the TSC1 or TSC2 gene are frequently autistic (Curatolo et al., 2008). Thus, the 
cerebellum is not only important for motor control but is implicated in non-motor behaviour 
(Schmahmann et al., 2007; Wang et al., 2014). Importantly, the behavioural deficits of the 
conditional TSC1 knockout mice could be reversed by treatment with the mTORC1 inhibitor 
rapamycin (Tsai et al., 2012). Consequently, rapamycin and analogues thereof (called 
rapalogs) are in clinical trials or are already on the market (everolimus) for the treatment of 
patients with TSC (Lipton & Sahin, 2014). However, little is known of how long-term 
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inactivation of mTORC1 affects mature neurons. Moreover, prolonged rapamycin treatment is 
known to also affect the function of mTORC2 (Sarbassov et al., 2006). Hence, an analysis 
and comparison of mTORC1 and mTORC2 functions in developing and adult neurons is 
needed. Here, we addressed this question by conditionally deleting Rptor (gene encoding 
raptor) or Rictor in mouse Purkinje neurons. Our results show that the two complexes 
differentially affect synapse development, Purkinje cell survival and mouse behaviour.   
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MATERIALS AND METHODS 
Mouse strains. All animal procedures complied with Swiss animal experimental regulations. 
C57BL/6 mice expressing the Cre recombinase under the endogenous L7/Pcp-2 promoter 
(L7/Pcp-2
Cre/+
) (Saito et al., 2005) were crossed with mice carrying floxed alleles coding for 
raptor (Rptor
loxp/loxp
), rictor (Rictor
loxp/loxp
) (Bentzinger et al., 2008) or TSC1 (Tsc1
loxp/loxp
) 
(Kwiatkowski et al., 2002) to obtain the following mouse lines: L7/Pcp-2
Cre/Cre
; Rptor
loxp/loxp
, 
L7/Pcp-2
Cre/Cre
; Rictor
loxp/loxp
 and L7/Pcp-2
Cre/Cre
; Tsc1
loxp/loxp
 that were called RAPuKO, 
RIPuKO or TSCPuKO, respectively. Mice investigated were all homozygous for the L7/Pcp-
2-Cre allele because of the higher percentage of recombination of the floxed alleles 
(Thomanetz et al., 2013). Controls for RAPuKO, RIPuKO or TSCPuKO mice were proper 
littermates with the following genotype L7/Pcp-2
Cre/Cre
; Rptor
loxp/+
, L7/Pcp-2
Cre/Cre
; 
Rictor
loxp/+
 and L7/Pcp-2
Cre/Cre
; Tsc1
loxp/+
, respectively. To label cells undergoing Cre-
mediated recombination, a Rosa26 locus-targeted EGFP reporter carrying a loxp stop cassette 
between the promoter and the coding sequence (R26-EGFP
T/+
 (Tchorz et al., 2012)) was 
crossed into the RAPuKO or RIPuKO background. The resulting knockout mice of the 
following genotype L7/Pcp-2
Cre/Cre
; Rptor
loxp/loxp
; R26-EGFP
T/+ 
and L7/Pcp-2
Cre/Cre
; 
Rictor
loxp/loxp
; R26-EGFP
T/+
 are referred to as RAPuKO GFP or RIPuKO GFP, respectively, 
and littermates of the L7/Pcp-2
Cre/Cre
; Rptor
loxp/+
; R26-EGFP
T/+
 and L7/Pcp-2
Cre/Cre
; 
Rictor
loxp/+
; R26-EGFP
T/+
 genotype were used as respective controls. For the conditional 
knockout of Rptor in neural progenitors (RAbKO), mice previously described were used 
(Cloetta et al., 2013). Genotyping of the mice used toe tissue and was done as described 
elsewhere (Kwiatkowski et al., 2002; Cloetta et al., 2013; Thomanetz et al., 2013). The 
L7/Pcp-2
Cre/?
 locus was detected using primers Fw 5' TGTGGCTGATGATCCGAATA and 
Bw 5' GCTTGCATGATCTCCGGTAT resulting in an amplicon of 249 bp. L7/Pcp-2
Cre/Cre 
mice were identified using primers Fw 5’ GAAGGCTTCTTCAACCTGCT and Bw 5’ 
ATATCCATGAGATTGTCCAT, resulting in the absence of a 292 bp. To detect EGFP 
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knocked-in at the Rosa26 locus a nested PCR was performed using primers Fw 5’ 
TGATATTGCTGAAGAGCTTGGCGGC and Bw 5’ TGTGTGTATTCCTGGCTATCC for 
the first PCR (35 cycles) and Fw 5’ AGCGCATCGCCTTCTATCGCC and Bw 5’ 
TGATGTGTAGACCAGGCTGG for the second PCR (25 cycles) resulting in an amplicon of 
253 bp.  
 Antibodies. -Tubulin (Mouse, BD Pharmingen, #556321, 1:500), CAR8 (Goat, 
Watanabe lab (Patrizi et al., 2008), 1:5000), calbindin D28k (Guinea pig, Synaptic Systems, 
#214 004, 1:500), calbindin D-28k (Mouse, Swant, #300, 1:2500), cleaved caspase-3 
(Asp175) (Rabbit, Cell Signaling, #9661, 1:300), cytochrome c clone 6H2.B4 (Mouse, BD 
Pharmingen, #556432, 1:100), glial fibrillary acidic protein (GFAP) clone CA5 (Mouse, 
Millipore, #MAB360, 1:100), GABAA α1 subunit (Guinea pig, (Fritschy et al., 2006), 
1:5000), GAD65 (Monoclonal GAD-6, DSHB, Iowa, 1:1000), GFP (Chicken, Molecular 
probes, #A10262, 1:500), GSK3 (Rabbit, Cell Signaling, #9338, 1:1000), GSK3 (Rabbit, 
Cell Signaling, #9315, 1:1000), phospho-GSK3α/β (Ser21/9) (Rabbit, Cell Signaling, #9331, 
1:1000), neurofilament H (Rabbit, Millipore, #AB1989, 1:200), phosphorylated 
neurofilaments (Mouse, Covance, #SMI-31P, 1:1000), phospho-S6 ribosomal protein 
(Ser235/236) (Rabbit, Cell Signaling, #2211, 1:100), PKC (Rabbit, Santa Cruz, #sc-211; 
1:100), synaptophysin (Rabbit, GeneTex, #GTX100865, 1:100), fluorescein (DTAF) 
streptavidin (Jackson ImmunoResearch, #016-010-084, 1:300), Cy3-streptavidin (Jackson 
ImmunoResearch, #016-160-084, 1:1000) 
 Tissue homogenization and Western blot analysis. Brains were dissected, transferred to 
protein lysate buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-
100 supplemented with EDTA-free protease inhibitor cocktail tablets (Roche), and 
phosphatase inhibitor tablets PhosSTOP (Roche)), and homogenized with a glass/Teflon 
homogenizer using 10 strokes at 800 rpm. The homogenate was centrifuged at 13,600 g for 15 
min at 4°C. Cleared lysates were used to determine total protein amount (BCA Protein Assay; 
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Thermo Fisher Scientific). After dilution with 5x SDS sample buffer, equal protein amounts 
were loaded onto SDS gels. 
 Immunohistochemistry. Mice were deeply sedated with isoflurane. After decapitation, the 
brain was rapidly removed and immediately transferred into ice-cold, oxygenated (95% O2, 
5% CO2), standard artificial cerebrospinal fluid (ACSF) containing (in mM) 119 NaCl, 1 
NaH2PO4, 2.5 KCl, 2.5 CaCl2, 1.3 MgCl2, 11 D-glucose and 26.2 NaHCO3. 250-µm-thick 
sagittal sections of cerebella were cut with a Leica VT1200S vibratome and transferred to 
oxygenated standard ACSF at room temperature and allowed to recover for about 30 min. 
Sections were fixed in 2-3 ml 4% paraformaldehyde (PFA) in PBS for at least 20 minutes and 
subsequently 3 times rinsed for 20 min with PBS. Slices were then stored overnight or longer 
at 4°C in 30% (w/v) sucrose in 0.1 M sodium phosphate buffer pH 7.4. The cryoprotected 
slices were then re-sliced as previously described (Schneider Gasser et al., 2006). In brief, the 
slices were shortly rinsed in ice-cold PBS and then mounted on a pre-cut frozen block of 
O.C.T. (optimal cutting temperature compound) and stored for 30 min at -20°C. 15-m-thick 
cryosections were made with a Leica CM1950 cryostat with a cryochamber and object head 
temperature of -20°C and -12°C, respectively, and subsequently stored at -20°C. Cryosections 
were thawed for about 2 min at 37°C and then incubated with blocking buffer (10% fetal 
bovine serum (FBS) and 0.2% Triton X-100 in PBS) for 1 h at room temperature. The 
primary antibodies were applied in blocking buffer overnight at 4°C and after washing in PBS 
(3 x 10 min), the corresponding secondary antibodies were added for 1 h at room temperature 
in blocking buffer. After washing in PBS (3 x 10 min), the slides were drained and 
coverslipped using Kaiser’s glycerol gelatine (Merck, #1.09242.0100). 
 For GABAA 1 stainings, mice were deeply anesthetized with pentobarbital (Nembutal, 
50 mg/kg, i.p.) followed by transcardiac perfusion with ice-cold standard ACSF at a flow rate 
of 10–15 ml/min (Notter et al., 2014). The brains were extracted immediately after the 
perfusion and postfixed in ice-cold 4% PFA in 0.15 M sodium phosphate buffer, pH 7.4 for 
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90 min. Tissue was then cryoprotected with 30% sucrose in PBS (w/v). Sagittal sections 
(thickness 40 µm) were cut from frozen blocks with a sliding microtome (Microm Heidelberg, 
HM 400). Sections were collected in PBS and stored at -20°C in anti-freeze solution (15% 
glucose and 30% ethylene glycol in 50 mM sodium phosphate buffer, pH 7.4) prior use. Free-
floating sections were incubated overnight at 4°C with primary antibodies and for 30 min at 
room temperature with secondary antibodies in Tris-HCl buffer, pH 7.4, containing 2% 
normal goat (or donkey) serum and 0.2% Triton X-100.  
 Fluoro-Jade B staining. Cryosections were thawed and dried at room temperature. The 
sections were first incubated for 5 min with 1% sodium hydroxide in 80% ethanol and then 
for 2 min with 70% ethanol for rehydration. The slides were transferred to 0.06% potassium 
permanganate for 10 min. Subsequently, they were rinsed for 2 min with ddH2O and 
incubated with the staining solution for 20 min in the dark. The staining solution contained 2 
μg/ml Fluoro-Jade B (FJB; Merck Millipore, #AG310) and 2 μg/ml Hoechst 33342 in 0.1% 
acetic acid. The slides were then washed three times 1 min in ddH2O, drained and dried at 
50°C. The dried slides were cleared in xylene for at least 1 min, drained and coverslipped 
using D.P.X. mounting medium (Sigma, #3176116). 
 Staining of biocytin-labelled Purkinje cells in acute slices. Purkinje cells were labelled 
with biocytin by the cell patch clamp method using intracellular solutions containing 3 mg/ml 
biocytin. The orientation of the acute slice was noted for the whole-cell recordings. The 
staining procedure was adapted from (Wierenga et al., 2008). In brief, after the recording, 
slices were fixed overnight at 4°C in 4% PFA dissolved in PBS. Slices were extensively 
rinsed with PBS and subsequently incubated for 24 h at 4°C in blocking solution (10% FBS in 
PBS, containing 0.4% Triton X-100) on a shaker. The primary antibody was applied 
overnight at 4°C in blocking solution (5% FBS in PBS; 0.4% Triton X-100) on a shaker. After 
extensive washing with PBS, appropriate secondary antibodies were applied overnight at 4°C 
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in blocking solution. Acute slices were mounted in Kaiser's glycerol gelatine with the patched 
side facing up. Stained slices were analysed by confocal microscopy.  
 Image acquisition. Fluorescence pictures were taken using a Leica 5000B microscope 
with a 10x (NA 0.4) or 20x (NA 0.5) objective in combination with the software AnalySIS 
(Soft Imaging System). Confocal pictures were taken using the Leica TCS SPE confocal 
system with a 20x (NA 0.7), 40x (NA 1.15), 63x (NA 1.3) or 100x (NA 1.47) oil immersion 
objective or with a Zeiss LSM 710 microscope with a 63x lens (NA 1.4). For GFAP stainings 
whole automated multiple image acquisitions were made with the Olympus IX81 using a 10x 
objective (NA 0.3).  
 Quantification. For image analysis and processing, ImageJ was used. All analyses were 
done on sagittal sections of the cerebellar vermis. To analyse Purkinje cell density and soma 
size, fluorescence pictures of calbindin stainings taken from the cerebellar lobes IV & V using 
a 10x objective were used. Purkinje cell density was determined by dividing the number of 
Purkinje cells by the length of the analysed Purkinje cell layer segment and is indicated in 
cells per mm. Data of RIPuKO, RIPuKO GFP and corresponding control mice were pooled. 
For Purkinje cell soma size analysis, only somata were included where the primary dendrite 
was clearly visible. For each mouse, the mean Purkinje cell density and soma size of n ≥ 3 
cerebellar slices was determined.  
 Quantification of apoptotic cells, axonal swellings or FJB patches was done by counting 
their appearance in the entire cerebellar slice (n ≥ 3 slices per mouse). For each mouse, the 
cerebellar slices were binned according to the number of observed events on the entire slice 
and finally the fraction of slices assigned to each bin was calculated. Apoptotic cells were 
positive for cleaved caspase-3 and showed a pyknotic nucleus. Calbindin staining was used to 
quantify axonal swellings of Purkinje cells in the granule cell layer.  
 The area covered by the dendritic tree of Purkinje cells was determined by merging z-
stacks of confocal images (taken with 20x or 40x objectives) from biocytin-labelled Purkinje 
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cells that were detected by fluorescein (DTAF) streptavidin in acute slices. The entire 
dendritic tree was encircled by connecting the most apical points of the dendritic branches and 
the covered area was determined. Purkinje cell dendrite self-crossings were quantified on 
confocal pictures taken with a 63x objective from re-sliced (15 m thick), biocytin-labelled 
Purkinje cells of RIPuKO GFP or corresponding control mice that were stained with Cy3-
streptavidin. Merged z-stacks of confocal pictures taken from randomly chosen regions of 
spiny distal branches of biocytin-labelled cells were analysed for self-crossings. The number 
of dendritic self-crossings was normalized to the analysed area and the normalized values of 
RIPuKO GFP mice were then set in relation to the ones of control mice. The experimenter 
was blinded to the mouse genotype. GABAA 1 subunit clusters and GAD65-positive 
terminals were quantified based on threshold segmentation using self-written macros for 
ImageJ and Excel.  
 Electrophysiology. Sagittal cerebellar slices were prepared as described above in low 
calcium ACSF containing (in mM) 119 NaCl, 1 NaH2PO4, 2.5 KCl, 0.125 CaCl2, 3.3 MgCl2, 
11 D-glucose and 26.2 NaHCO3. Slices were then transferred for 30 min to 34°C-warm, 
oxygenated standard ACSF and subsequently stored in oxygenated standard ACSF at room 
temperature until they were used. Whole-cell recordings were taken at room temperature 
using an Axon MultiClamp 700A or 700B amplifier (Molecular Devices) and borosilicate 
glass pipettes (2-4 MΩ).  
 Internal solutions always contained biocytin (3 mg/ml) and cells were always analysed by 
immunohistochemistry as described above to confirm recombination of the targeted alleles in 
the recorded cell. The following internal solutions were used for the different recordings: for 
passive membrane properties (in mM) 140 K-gluconate, 4 NaCl, 2 MgCl2, 5 HEPES, 1.1 
EGTA, 2 Na2-ATP, 0.6 mM Na3-GTP, 5 sodium creatine phosphate, pH 7.3; for mEPSCs and 
mIPSC (in mM) 135 Cs-methanesulfonate, 8 NaCl, 10 HEPES, 0.5 EGTA, 4 Mg-ATP, 0.3 
Na-GTP, 5 Lidocaine-N-ethyl bromide, pH 7.25; for climbing fibre stimulation (in mM) 150 
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CsCl, 1.5 mM MgCl2, 10 HEPES, 0.1 EGTA, 2 Mg-ATP, 0.4 Na-GTP, 5 Lidocaine-N-ethyl 
bromide, pH 7.3; for LTD recordings (in mM) 65 Cs-methanesulfonate, 65 K-gluconate, 10 
KCl, 1 MgCl2, 20 HEPES, 0.4 EGTA, 4 Na2-ATP, 1 mM Na2-GTP, 5 sucrose, pH 7.3.  
 Passive membrane properties in RAPuKO, RAPuKO GFP, RIPuKO, RIPuKO GFP and 
corresponding control mice were measured in voltage clamp mode in response to a 
rectangular hyperpolarization from -60 mV to -80 mV for 300 ms using the pClamp system 
(Molecular Devices, version 10.2). 
 mEPSCs and mIPSCs were recorded in the presence of 0.5 µM TTX and at a holding 
potential of -70 mV and 0 mV, respectively, using the pClamp system. Traces were further 
analysed with the Mini Analysis Program v6 (Synaptosoft). Default settings of this program 
were used to automatically detect peaks. The peak detection algorithm is designed to first find 
a local maximum and then a baseline and subsequently differentiates between real peaks and 
noise-peaks by a threshold for the area under the curve. All detected events were manually 
cross-checked for correctness. 
 Climbing fibre innervation was analysed by placing a patch pipette (2 MΩ), filled with 
standard ACSF, in the granule cell layer in the vicinity of the patched Purkinje cell. Two 
current pulses (0.1 ms, paired-pulse interval: 62.5 or 100 ms) generated by a stable IS4 
stimulator (SC-Devices) were applied every 20 s. The stimulation pipette was moved in the 
granule cell layer until the climbing fibre response (CF-EPSC) could be elicited with minimal 
stimulation intensity. The holding potential was set at -10 mV to inactivate voltage-gated 
conductances and to reduce the driving force. The stimulation intensity was reduced until all 
synaptic responses disappeared and was progressively increased again. The climbing fibre 
response as a function of the stimulation intensity was analysed and only events showing 
paired-pulse depression as well as a clear threshold were included for analysis. The number of 
innervating climbing fibres was estimated from the number of discrete CF-EPSC steps. 
Climbing fibre recordings were made and analysed using the pClamp system. For climbing 
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fibre analysis, 4-week-old RIPuKO and 12-week-old RIPuKO GFP mice and corresponding 
littermate control mice were used. 
 For LTD recordings, acute cerebellar slices were perfused with standard ACSF 
containing 100 M picrotoxin (Sigma #P1675) and a patch pipette (2 MΩ) filled with 
perfusion solution was placed in the molecular layer in the vicinity of the voltage-clamped 
Purkinje cell. Parallel fibre (PF) responses were elicited by applying two current pulses using 
a stable IS4 stimulator (0.2 ms, paired-pulse interval: 100 ms) every 10 s while the cell was 
held at -60 mV. The stimulation intensity was chosen to obtain a PF-EPSC response of 
approximately -200 pA. A baseline was recorded for at least 10 min and when judged stable, 
LTD was induced by increasing the holding potential from -60 to +20 mV for 500 ms in 
conjunction with a single PF stimulus, which was repeated 30 times at a frequency of 1 Hz. 
Access resistance was measured every 10 s and recordings were discarded if it changed by 
more than 20% from the initial value. LTD was recorded and analysed using IGOR Pro 
software (WaveMetrics).  
 Behavioural assays. Mice were housed in a standard colony room with a 12:12 light:dark 
cycle and food and water was provided ad libitum. For behavioural tests, mice were 
transferred to a separate room at least 1 h prior to the experiment for adaptation. Tests were 
performed at the same time of day and the experimenter was blinded to the mouse genotype. 
 Balance beam test. For the balance beam test, a 70-cm-long, wooden beam, which was 
covered with masking tape, was horizontally connected to a dark box. The entire system was 
elevated to preventing mice to jump off. The starting area was brightly illuminated to 
motivate the mice to move towards the dark target box. The number of slips of the hind legs 
was counted. Mice were given 2 training sessions prior to the test session, each session 
consisted of 3 runs. During the training sessions, the diameter of the beam was gradually 
decreased. 4- to 8-week-old, female RIPuKO and 9- to 11-week-old, male RAPuKO mice and 
corresponding littermate controls were tested on a 1.1-cm-thick beam. For 14- to 20-week-
  P a g e  | 13 
old, female RIPuKO and 29- to 41-week-old, male RAPuKO mice and the corresponding 
littermate controls, the diameter of the beam was 1.3 cm. For each mouse, the mean number 
of slips from three runs was calculated.  
 Footprint analysis. Paws of the mice were painted with non-toxic paint (forepaws in red, 
hindpaws in black). Mice were placed into an acrylic glass corridor of 1 m length and 8 cm 
width. The corridor was lined with white paper. The starting point was brightly illuminated to 
motivate the mouse to walk towards the dark box placed at the end of the corridor. For 
analysis, ten steps during which the mouse walked continuously and did not touch the wall 
were selected. The paper stripes were scanned, the coordinates of the footprints were 
evaluated using ImageJ and the mean gait width of the ten steps was calculated for each 
mouse. Female RIPuKO and male RAPuKO mice and corresponding littermate control mice 
of the indicated age were used for the footprint analysis. 
 Olfactory habituation/dishabituation. Olfactory habituation/dishabituation tests were 
performed as previously described (Yang & Crawley, 2009; Silverman et al., 2010). 9- to 11-
week-old male RAPuKO mice and 13- to 26-week-old RIPuKO and RIPuKO GFP mice and 
corresponding littermate control mice were used. In brief, mice were accommodated to a fresh 
cage with a clean and dry cotton tipped swab (cotton tip 2 cm over the cage ground) 
suspended from the cage lid for 30 min. After this acclimation period, odours were presented 
for 2 min in intervals of 1 min and the time of interest of the mouse in the cotton swab was 
measured. Interest was scored if the nose of the mouse was within 2 cm of the cotton tip. 
Odours were presented twice or three times to analyse olfactory habituation. The order of 
presented odours was water, water, banana, banana, social odour 1, social odour 1, social 
odour 1, social odour 2, social odour 2, social odour 2. For the water and banana odours, 100 
l of ddH2O or isoamyl acetate (Sigma #W205532) diluted 1:1500 in ddH2O were dripped 
onto the cotton tip. Social odours were obtained by wiping the cotton tipped swab in a zig-zag 
pattern across the bottom surface of a cage that had been used by 3-4 age-matched, unfamiliar 
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male mice of the same strain (C57BL/6) for 7 days. Results of RIPuKO and RIPuKO GFP 
mice and the corresponding control mice were pooled. Raw data were cleaned from statistical 
outliers by GraphPad prism software (ROUT method; Q = 0.1%) prior to statistical analysis.  
 Statistics. All data are presented as mean ± SEM. An unpaired Student’s t-test or a one- 
or two-way ANOVA followed by a Tukey’s or a Bonferroni’s post hoc test was used to 
analyse data for statistical significance. A probability of 0.05 was taken as the level of 
statistical significance. Statistical analyses were performed using Prism software version 6.05 
(GraphPad, San Diego, CA, USA).  
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RESULTS 
 
Motor deficits and social behaviour of RAPuKO and RIPuKO mice 
Purkinje cell-specific ablation of mTORC1 or mTORC2 was achieved by crossing L7/Pcp-2-
Cre mice (Saito et al., 2005) with Rptor
loxp/loxp
 or Rictor
loxp/loxp
 mice (Bentzinger et al., 2008) 
as previously described (Thomanetz et al., 2013). The resulting mouse lines are called 
RAPuKO or RIPuKO (for raptor- or rictor Purkinje cell knockout). L7/Pcp-2-driven Cre 
expression starts at embryonic day 17.5 (E17.5) (Saito et al., 2005) and hence this Cre driver 
deletes the targeted alleles during Purkinje cell development (Watanabe & Kano, 2011).  
 As Purkinje cells provide the sole output of the cerebellar cortex and are known to be 
essential for motor control, we first analysed how raptor and rictor depletion affected motor 
coordination. For this reason, RAPuKO and RIPuKO mice were tested on a balance beam and 
the number of hind leg slips that occurred during the crossing was counted. In RIPuKO mice, 
the number of slips was significantly increased compared to control littermates independent of 
age (4-8 weeks: t21 = 2.6, P = 0.017; 14-20 weeks: t17 = 3.2, P = 0.0054; Fig. 1A). In contrast, 
young RAPuKO mice did not show any motor coordination deficits, whereas a significant 
deficit was noted at the age of 29-41 weeks (9-11weeks: t23 = 0.94, P = 0.36; 29-41 weeks: t32 
= 3.07, P = 0.0044; Fig. 1B). In addition to the early-onset coordination deficits, RIPuKO 
mice showed an increase in the gait width of their hind legs (t16 = 2.99, P = 0.0087; Fig. 1C), 
whereas RAPuKO mice did not show any change in gait (t15 = 0.53, P = 0.61; Fig. 1D;). Thus, 
mTORC2 deficiency in Purkinje cells results in early deficits in motor coordination whereas 
inactivation of mTORC1 affects this behaviour only at a rather high age. 
 Recent reports have shown that Purkinje cell-specific depletion of TSC1, which results in 
sustained activation of mTORC1, causes autism spectrum disorder-like changes in mice that 
manifest by altered social behaviour (Tsai et al., 2012). To evaluate whether a similar 
phenotype could also be noted in mice deficient for mTORC1, we tested RAPuKO mice in an 
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olfactory habituation/dishabituation test. To rule out that motor deficits interfered with this 
test, we used young mice. While RAPuKO mice spent the same time sniffing non-social 
odours as control mice, the interest in social odours was significantly reduced (F1,218 = 24.3, P 
< 0.01; Fig. 1F). As depletion of TSC1 also affects mTORC2 signalling (Goto et al., 2011; 
Carson et al., 2012), we also tested RIPuKO mice in the same behavioural paradigm. 
However, no significant difference in the interest in either non-social or social odours was 
observed (F1,381 = 7.5, P > 0.05; Fig. 1E). These data indicate that mTORC1 and mTORC2 
have distinct functions in Purkinje cells as the phenotypes in motor coordination and social 
interest are distinct. 
 
Morphology and synaptic alterations in Purkinje cells of RAPuKO mice 
Expression of Cre under the control of the L7/Pcp-2 promoter is mosaic in Purkinje cells 
(Saito et al., 2005). Similarly, we have previously shown that rictor is depleted in only 75% of 
the Purkinje cells in RIPuKO mice and that lack of expression of PKCγ is a reliable marker 
for successful removal of rictor (Thomanetz et al., 2013). To test whether a similar mosaic 
pattern was observed in RAPuKO mice, we stained sagittal sections of the cerebellum for the 
phosphorylated form of S6 (pS6), which is activated by mTORC1 (Wullschleger et al., 2006). 
Thus, lack of pS6 was used as an indicator of successful depletion of raptor. In young, 3- to 
11-week-old RAPuKO mice, 49 ± 5% (mean ± SEM; n = 19 mice) of the Purkinje cells were 
negative for pS6 (pS6(-)) while all Purkinje cells of control mice were pS6-positive (pS6(+)) 
(Fig. 2A). To validate that lack of pS6 was indeed indicative of raptor depletion, a GFP 
reporter mouse for Cre-mediated recombination (Tchorz et al., 2012) was crossed into the 
RAPuKO background. In those mice, called RAPuKO GFP, 98 ± 1% (mean ± SEM; n = 3 
mice) of the pS6(-) Purkinje cells of 11-week-old mice were also GFP-positive (GFP(+)) 
whereas 83 ± 3% (mean ± SEM; n = 3 mice) of the pS6(+) Purkinje cells were GFP-negative 
((GFP(-)). In comparison to GFP(-)/pS6(+) Purkinje cells, the soma size of GFP(+)/pS6(-) 
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Purkinje cells was reduced by 59% (F2,6 = 129.4, P < 0.0001; Supporting fig. 1A and C), 
consistent with the role of mTORC1 in the control of cell size. 10% of Purkinje cells of 
RAPuKO GFP mice were GFP(+) and pS6(+) (Supporting fig. 1A and B). Together, these 
data show that lack of pS6 is a reliable marker for raptor depletion in Purkinje cells. 
 A reduction in soma size by 40-50% could be detected in the pS6(-) Purkinje cells of 
RAPuKO mice already at the age of 3 weeks when compared to Purkinje cells of age-matched 
control mice (F2,6 = 28.3, P = 0.0017; Fig. 2B). Notably, this reduction remained the same in 
RAPuKO mice at higher age (6 weeks: F2,8 = 32.8, P = 0.0009; 11 weeks: F2,9 = 28.3, P = 
0.0026; 20-42 weeks: F2,9 = 59.1, P = 0.001; Fig. 2B). On the other hand, a small but 
significant increase in the soma size of the pS6(+) Purkinje cells in older RAPuKO mice 
could be observed in comparison to Purkinje cells of the corresponding control mice (20-42 
weeks: F2,9 = 59.1, P = 0.0011; Fig. 2B). Next to a reduction in soma size, raptor-depleted 
Purkinje cells also showed a decrease in the area covered by the dendritic tree by 42 ± 3% 
(mean ± SEM; n ≥ 36 cells using n = 7 mice; two-tailed Student’s t-test: t74 = 9.1, P < 0.0001; 
Fig. 2C). Additionally, more than 40% of raptor-depleted Purkinje cells of 4- to 6-week-old 
RAPuKO mice contained multiple primary dendrites (Fig. 2C and D) while ~90% of Purkinje 
cells in control mice had only one primary dendrite. Multiple primary dendrites at a similar 
frequency were also observed in RIPuKO mice (Thomanetz et al., 2013). However, Purkinje 
cells of RAPuKO mice were all positive for the mTORC2 downstream target PKC (Fig. 2E), 
indicating that mTORC1 ablation in Purkinje cells does not affect mTORC2 signalling, in line 
with previous data (Cloetta et al., 2013). In summary, raptor depletion in Purkinje cells results 
in severe, morphological changes. Although rictor depletion also affects the size of Purkinje 
cells (Thomanetz et al., 2013), the effect in RAPuKO mice is much stronger.  
 To test whether the morphological changes in raptor- and rictor-deficient Purkinje cells 
resulted in changes in their function, passive membrane properties were next measured in 
whole-cell recordings. Purkinje cells in RAPuKO mice were selected by their soma size, 
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patched and recorded with pipettes filled with biocytin. After recording, the morphology of 
the recorded, biocytin-filled Purkinje cell was visualized and raptor deficiency was confirmed 
by pS6 staining (Supporting fig. 2A - C). As expected from the small soma size of raptor-
depleted Purkinje cells, capacitance was decreased (F2,55 = 289.8, P < 0.0001; Supporting fig. 
2D) and membrane resistance was increased (F2,55 = 56.9, P < 0.0001; Supporting fig. 2E). 
Both parameters were also altered in RIPuKO mice (capacitance: t44 = 6.3, P < 0.0001; 
membrane resistance: t44 = 5.3, P < 0.0001; Supporting fig. 2D and E), consistent with the 
previous finding that their somata are smaller (Thomanetz et al., 2013). Hence, the reduction 
of the soma size and the concomitant alterations of their passive membrane properties are 
reliable markers for raptor deficiency. 
 Synapse function was examined by measuring miniature excitatory and inhibitory 
postsynaptic currents (mEPSC and mIPSC, respectively). While there was no difference in the 
mEPSCs of raptor-deficient Purkinje cells at the age of 6 weeks compared to cells in control 
mice (mEPSC frequency: t24 = 0.49, P = 0.63; mEPSC amplitude: t24 = 0.056, P = 0.96; Fig. 
3A – C), a pronounced reduction in the frequency of mIPSCs (t28 = 4.065, P = 0.0004; Fig. 
3D and E), but not the amplitude (t28 = 0.22, P = 0.83; Fig. 3D and F), was observed. By 
quantitative immunohistochemistry using antibodies against the 1 subunit of GABAA 
receptors, we also found that the mean number of GABAA 1 clusters on the somata of pS6(-) 
Purkinje cells was reduced by 43% (t8 = 4.46, P = 0.0021; Fig. 3G and I). In contrast, no 
change in the density of the GABAA 1 clusters was seen in the molecular layer (t7 = 0.15, P 
= 0.88; Fig. 3H and J), which might be based on the high percentage (~40%) of inhibitory 
synapses on interneurons (Briatore et al., 2010). Interneurons are not targeted by the 
conditional knockout. Together, our data indicate a lowering of the number of inhibitory 
synapses formed onto raptor-deficient Purkinje cells. 
 Raptor deficiency also affected the size of GABAergic synapses but this effect differed 
between the soma and the molecular layer. While the size of GABAA α1 clusters on the 
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somata of raptor-deficient Purkinje cells was increased (t1644 = 5.9, P < 0.0001; Fig. 3K), the 
size of GAD65/GABAA α1-positive clusters in the molecular layer was smaller (t1384 = 2.81, 
P = 0.005; Fig. 3L), which may explain why we could not detect any alteration in the 
amplitude of the mIPSCs as the size differences may cancel each other out. In summary, these 
data indicate a misbalance between the inhibitory and the excitatory input in Purkinje neurons 
that are deficient of raptor. Such a misbalance, in turn, might contribute to the behavioural 
deficit in social interest of RAPuKO mice. Noteworthy, rictor knockout in Purkinje cells 
affects both excitatory and inhibitory synaptic properties (Thomanetz et al., 2013). 
 
Multiple climbing fibre innervation accounts for ataxia of RIPuKO mice  
Rictor knockout in Purkinje cells is paralleled by a striking down regulation of PKC 
(Thomanetz et al., 2013), the major PKC isoform expressed by these neurons (Barmack et al., 
2000). Mice with a conventional knockout of PKC show impaired motor coordination (Chen 
et al., 1995). This motor coordination deficit is paralleled by multiple innervation of Purkinje 
cells by climbing fibres (CF) (Kano et al., 1995). As RIPuKO mice showed a motor 
coordination phenotype (Fig. 1), we analysed CF innervation by measuring EPSCs in Purkinje 
cells by whole-cell recordings in response to electrical stimulation of CFs. Several parameters 
of the CF-EPSCs were altered in rictor-deficient Purkinje cells (Table 1), which is probably 
due to their morphological changes. When we analysed mice at the age of 4 weeks, which is 
one week after synapse elimination is completed (Hashimoto & Kano, 2013), more than 90% 
of the control Purkinje cells showed uniform CF-EPSCs, indicative of single CF innervation 
(Fig. 4A and D). In contrast, several distinct CF-EPSCs were measured for ~ 40% of Purkinje 
cells in RIPuKO mice, indicative of multiple innervation (Fig. 4B and D). In addition, paired-
pulse depression (PPD) of CF synapses was slightly increased in RIPuKO compared to 
control mice (Fig. 4B; Table 1). To rule out that multiple CF innervation was simply due to a 
delay in CF elimination, we also measured CF-EPSC responses in 12-week-old RIPuKO 
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mice. The percentage of knockout cells showing multiple discrete steps in CF-EPSC 
responses was very similar to those in young mice (Fig. 4C and D), indicating that multiple 
CF innervation of rictor-knockout Purkinje cells persists throughout adulthood. Hence, 
multiple CF innervation, like in PKC knockout mice, might be responsible for the motor 
deficits in RIPuKO mice. In contrast, 4-week-old RAPuKO mice did not show multiple CF 
innervation (Fig. 4E – G). However, similar to rictor-deficient Purkinje cells, PPD of CF-
EPSCs was slightly increased in raptor-depleted Purkinje cells and morphological changes 
were also paralleled by altered CF-EPSC properties (Table 1).  
 Another cellular correlate implicated in altered motor behaviour is a failure to undergo 
cerebellar long-term depression (LTD) (Kano et al., 2008; Hirano, 2013). Cerebellar LTD is 
induced by simultaneous stimulation of parallel fibre (PF) and CF synapses, which leads to a 
profound depolarization of the Purkinje cell and a weakening of the PF synapse. Because 
rictor-deficient Purkinje cells are frequently innervated by multiple CFs, LTD was induced by 
directly depolarizing the voltage-clamped Purkinje cell via the recording electrode and 
simultaneously stimulating the PFs (Fig. 4H) (Kakegawa et al., 2011). Although some of the 
kinetics of the PF-EPSCs was slightly altered in RIPuKO mice (Table 1), the LTD-inducing 
protocol caused a similar reduction of the PF-EPSCs in both control and rictor-deficient 
Purkinje cells (t15 = 0.33, P = 0.74 (analysed 30 min after LTD induction); Fig. 4I - K). These 
experiments show that cerebellar LTD is normal in RIPuKO mice and thus exclude this as a 
mechanism responsible for the changed motor behaviour.  
 Impairment of gait and motor coordination has also been correlated with an increased 
number of dendritic self-crossings of Purkinje cells, which has been suggested to result from 
defective dendritic self-avoidance (Gibson et al., 2014). Impaired dendritic self-avoidance is 
evident in Purkinje cells deficient of γ-protocadherins (Lefebvre et al., 2012), a class of 
molecules that acts via the mTORC2 target PKC (Garrett et al., 2012). Thus, we analysed 
dendritic self-avoidance in 12-week-old RIPuKO mice by re-slicing biocytin-labelled 
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Purkinje cells and staining them for Cy3-streptavidin and PKC.Confocal microscopy 
analysis of randomly selected regions of spiny distal branches of the dendritic tree (Fig. 4L 
and M) revealed a significant increase in the number of dendritic self-crossings in rictor-
knockout Purkinje cells (t67 = 4.7, P < 0.0001; Fig. 4N). Hence, loss of mTORC2 in Purkinje 
cells also decreases dendritic self-avoidance. In summary, failure in CF synapse elimination 
and hampered self-avoidance of dendrites might both contribute to the motor coordination 
phenotype of RIPuKO mice. Interestingly, both of those cellular phenomena have previously 
been linked to dysregulation of the mTORC2 target PKC. 
 
Age-dependent loss of Purkinje cells in RAPuKO but not RIPuKO mice due to apoptosis 
As described above, the motor coordination phenotype of RIPuKO mice was observed at an 
early age whereas the motor coordination deficits of RAPuKO mice were only observed at 
higher age. This together with the previous finding that ablation of mTORC1 causes increased 
apoptosis of neurons (Cloetta et al., 2013), led us to hypothesize that loss of Purkinje cells 
might underlie the age-dependent motor deficits of RAPuKO mice. To test this, we counted 
the number of Purkinje cells in RAPuKO and RIPuKO mice in the course of mouse ageing. 
While the density of the Purkinje cells remained the same in RIPuKO mice (3 weeks: t4 = 
0.044, P = 0.97; 18 weeks: t4 = 0.62, P = 0.57; 86-96 weeks: t4 = 1.77, P = 0.15; Fig. 5A and 
B), it significantly decreased in RAPuKO mice older than 11 weeks (3 weeks: t5 = 1.46, P = 
0.21; 6 weeks: t9 = 0.62, P = 0.55; 11 weeks: t6 = 2.31, P = 0.06; 17-29 weeks: t4 = 6.2, P = 
0.0034; 41-42 weeks: t4 = 7.75, P = 0.0015; Fig. 5C and D). To investigate whether cell loss 
was due to apoptosis, cells were stained for cleaved caspase-3 (CC3), a well-known apoptosis 
marker (Gown & Willingham, 2002). No CC3-positive Purkinje cells (CC3
+
 PCs) were found 
in 6-week-old RAPuKO mice (data not shown) but many positive cells could be detected at 
the age of 11 weeks (t6 = 5.26, P = 0.0019 (bin: 1 CC3
+
 PC per slice); Fig. 5E and F). Those 
cells also showed signs of a condensed and fragmented nucleus in the Hoechst staining (Fig. 
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5E), which is an additional characteristic of apoptosis (Robertson et al., 2000). The apoptotic 
events were also accompanied by the appearance of GFAP-positive fibres in the molecular 
layer (Fig. 5G and H). The localization of the GFAP-positive fibres and their palisade-like 
arrangement (Fig. 5H) suggested that these were Bergmann glia cells, which are known to be 
closely associated with Purkinje cells (Yamada & Watanabe, 2002). An increase of GFAP-
positive fibres is a hallmark of reactive astrogliosis that can be a consequence of 
neurodegeneration (Pekny & Nilsson, 2005). Thus, at a higher age, Purkinje cells in RAPuKO 
mice are lost because of apoptosis. Most probably, the age-dependent loss of Purkinje cells 
underlies the motor coordination deficits that are visible in old RAPuKO mice.  
 
Neurofilamentopathy upon ablation or sustained activation of mTORC1 in Purkinje 
cells 
To further investigate the cause of cell death in RAPuKO mice, we next stained for 
degenerating neurons using Fluoro-Jade B (FJB), a compound that specifically stains 
degenerating neurons (Schmued & Hopkins, 2000). FJB-positive puncta were visible in the 
molecular and Purkinje cell layer of 6- and 11-week-old RAPuKO but not of control mice (6 
weeks: t4 = 8.0, P = 0.0013 (bin: 1-5 FJB patches); 11 weeks: t4 = 4.0, P = 0.016 (bin: 6-10 
FJB patches); Fig. 6A and B), indicating that neurodegeneration preceded apoptosis in raptor-
knockout Purkinje cells. In addition, signs of dendritic atrophy and beading could be detected 
in biocytin-labelled, raptor-deficient Purkinje cells of 6-week-old mice (Fig. 6C) and 
swellings of axons proximal to raptor-deficient Purkinje cell somata were often detected 
whereas such swellings were only very rarely observed in control mice (6 weeks: t6 = 3.27, P 
= 0.017 (bin: 1-5 swellings); 11 weeks: t6 = 15.0, P < 0.0001 (bin: 5< swellings); Fig. 6D - 
H). Swollen axons are thought to be an early sign of axonal degeneration and have been 
reported to frequently contain organelles or cargo proteins, such as mitochondria, synaptic 
vesicles and neurofilaments (Ching et al., 1999; Louis et al., 2009; Watanabe et al., 2010; 
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Yang et al., 2013). In accordance, 84.8 ± 0.7% (mean ± SEM; n = 390 swellings of n = 4 
mice) of the axonal swellings in RAPuKO mice were strongly positive for neurofilament 
heavy (neurofilament H) (Fig. 6D) and 81.2 ± 5% (mean ± SEM; n = 196 swellings of n = 4 
mice) were positive for the phospho-neurofilament epitope (SMI31) (Fig. 6E). In contrast, the 
swellings did not show any accumulation of mitochondria (Fig. 6F) or synaptic vesicles (Fig. 
6G). Neurofilaments are known to undergo axonal transport and there is evidence that this is 
regulated by phosphorylation in the C-terminal KSP repeats (reviewed in (Shea et al., 2009; 
Holmgren et al., 2012)), and glycogen synthase kinase 3 (GSK3) has been shown to 
phosphorylate neurofilament H at the KSP repeats (Bajaj & Miller, 1997). Because 
phosphorylation of GSK3/ at residue Ser21/9 is downstream of Akt (Cross et al., 1995) and 
because changes in mTORC1 activity affect activation of Akt (Bentzinger et al., 2008), we 
examined phosphorylation of GSK3 in mice that lack raptor in all brain cells (Cloetta et al., 
2013). In those mice, phosphorylation of GSK3 was strongly increased (P-GSK3: t8 = 5.3, P 
= 0.0007; P-GSK3: t8 = 6.29, P = 0.0002; GSK3: t8 = 1.55, P = 0.16; GSK3: t8 = 0.88, P 
= 0.41; Fig. 6I and J), indicating that aberrant GSK3 signalling might be the cause of the 
axonal accumulation of neurofilaments in raptor-knockout Purkinje cells.  
 Similar proximal axonal swellings have also been reported in mice deficient for TSC1 in 
Purkinje cells (Tsai et al., 2012). Because TSC1 knockout in brain tissue is known to affect 
GSK3 signalling (Meikle et al., 2008), we hypothesized that the swollen axons in TSC1-
deficient Purkinje cells might also contain neurofilaments. Indeed, axonal swellings in 11-
week-old TSC1 Purkinje cell knockout (TSCPuKO) mice were in 78.5 ± 3% (mean ± SEM; n 
= 266 swellings of n = 4 mice) and 79.6 ± 2% (mean ± SEM; n = 276 swellings of n = 4 mice) 
of the cases clearly positive for neurofilament H (Fig. 7A) and phosphorylated neurofilament 
(Fig. 7B), respectively. At this age, few Purkinje cells underwent apoptosis and their density 
was reduced (data not shown), consistent with the observations by others (Tsai et al., 2012) 
that TSC1 deficiency reduces Purkinje cell survival. Like in RAPuKO mice, Purkinje cell 
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degeneration/apoptosis in TSCPuKO mice was paralleled by reactive Bergmann glia that 
manifested in palisade-like, GFAP-positive structures in the molecular layer (Fig. 7C). 
Altogether, these data show that both, ablation and sustained activation of mTORC1, results 
in a neurofilamentopathy, accompanied by the accumulation of neurofilaments in the axonal 
swellings proximal to the somata of Purkinje cells, and causes Purkinje cell death by 
apoptosis.   
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DISCUSSION 
Here, we describe the phenotypes of mice that lack mTORC1 or mTORC2 in developing and 
adult Purkinje cells. While some of the phenotypes, such as the changes in cell morphology, 
are shared between RAPuKO and RIPuKO mice, most of them differ between the two mouse 
models (Table 2). Phenotypes that are exclusive for the RAPuKO mice are (i) the reduced 
social interest and (ii) the progressive loss of Purkinje cells that starts at the age of 11 weeks 
(Table 2). Phenotypes exclusive to RIPuKO mice are (i) the early changes in motor 
coordination and the gait alterations and (ii) the impairment of CF synapse elimination (Table 
2). Thus, our work provides strong evidence that mTORC1 and mTORC2 have only a few 
common but many very distinct functions in Purkinje neurons although they share many of 
the molecular components including mTOR.  
 
A role of mTORC1 for the morphology of Purkinje cells 
Given the important role of mTORC1 for cell growth (Wullschleger et al., 2006), our 
observation that raptor-deficient Purkinje cells have smaller cell somata and a smaller 
dendritic tree is not surprising. The size difference was seen already at 3 weeks of age and 
persisted throughout adulthood. Thus, raptor-deficient Purkinje cells seem to never reach the 
size of wild-type neurons. The observed change of the dendritic tree in raptor-deficient 
Purkinje cells and, in particular, the presence of several primary dendrites was, however, not 
expected. The development of the Purkinje cell dendrites occurs mainly in the first three 
postnatal weeks. Purkinje cells transiently express multiple primary dendrites around birth 
and all but one are subsequently eliminated within the first two weeks. Later, the final size of 
the dendritic tree is established by a rapid and a slow growth phase (Sotelo & Dusart, 2009). 
While the detailed molecular mechanisms involved in this developmental reshaping of the 
dendrites are not well established, neuronal polarity is regulated by the PI3K-Akt-GSK3 
pathway (Arimura & Kaibuchi, 2007) and inhibition of GSK3 by phosphorylation increases 
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the number of primary dendrites in cultured neurons (Naska et al., 2006). Finally, brain-
specific deletion of the PI3K-Akt inhibitor PTEN results in the formation of ectopic dendrites 
in neurons, which correlates with increased phosphorylation of Akt and GSK3 (Kwon et al., 
2006). Inactivation of mTORC1 by raptor depletion increases Akt signalling (Cloetta et al., 
2013) because the inhibitory feedback loop via S6K is dampened (Um et al., 2004). Thus, 
increased GSK3 inhibition because of Akt-mediated phosphorylation in raptor-deficient 
Purkinje neurons may cause the multiple primary dendrites.  
 Interestingly, Purkinje cells deficient for rictor have also several primary dendrites 
(Thomanetz et al., 2013). Despite the similar phenotype to the RAPuKO mice, the underlying 
mechanism in RIPuKO mice is more likely based on abnormal PKC signalling including the 
dysregulation of its downstream targets MARCKS and GAP-43, as previously commented 
(Angliker & Ruegg, 2013). Consistent with this PKC-mediated mechanism, rictor-deficient 
Purkinje cells also exhibit extensive self-crossings of spiny distal dendritic branches. A very 
similar phenotype was also observed in mice deficient for -protocadherins, which also affect 
PKC signalling and its downstream target MARCKS (Garrett et al., 2012; Lefebvre et al., 
2012).  
 
Effect of mTORC1 and mTORC2 on synaptic connectivity 
While there is morphological similarity between Purkinje cells in RAPuKO and RIPuKO 
mice, alterations in their synaptic connectivity are rather distinct (Table 2). For example, 
excitatory synapses are not altered in raptor-depleted Purkinje cells as judged by their mEPSC 
amplitude or frequency, whereas rictor-depletion results in a strong reduction of mEPSC 
frequency (Thomanetz et al., 2013). Consistent with a function of mTORC2 at excitatory 
synapses, others have shown that late-phase LTP is affected in rictor-depleted hippocampal 
neurons due to impaired actin polymerization (Huang et al., 2013). We here also show that 
elimination of excitatory CF synapses is hampered in RIPuKO mice while LTD at PF-
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Purkinje cell synapses is not affected. The same phenotype has been reported in PKC 
knockout mice (Chen et al., 1995). Mechanistically, this phenotype has been explained by the 
role of PKC in postsynaptic mGluR1 signalling (Chen et al., 1995; Kano et al., 1995; 
Offermanns et al., 1997; Kano et al., 1998; Ichise et al., 2000), which drives CF synapse 
elimination via its regulating PF synaptic input (Kakizawa et al., 2000; Hashimoto & Kano, 
2013). Concordantly, Purkinje cells in mice deficient for PKCγ or other downstream 
regulators of mGluR1 signalling are innervated by multiple CFs and the mice show motor 
deficits. 
 Similar to excitatory, also inhibitory synaptic input is differently affected in RAPuKO 
and RIPuKO mice: RAPuKO mice show a pronounced reduction of mIPSC frequency 
whereas only small changes in mIPSC amplitude have been observed in RIPuKO mice (Table 
2) (Thomanetz et al., 2013). Consistent with the reduced mIPSC frequency of raptor-deficient 
Purkinje cells, the number of perisomatic GABAA 1 clusters was reduced. Raptor knockout 
also affected the size of GABAA 1 clusters but the effect depended on the subcellular 
localization. While GABAA 1 cluster size was increased on the somata of Purkinje cells, it 
was decreased in the dendrites (i.e. the molecular layer). In rats, the size of GABAA 1 
clusters on the soma of Purkinje cells has been shown to become reduced during the first three 
postnatal weeks whereas the size of GABAA 1 clusters in the molecular layer is increased 
(Viltono et al., 2008). As GABAA 1 cluster size is increased on the soma of knockout cells 
but decreased in the molecular layer in 6-week-old RAPuKO mice, it is possible that these 
changes are a consequence of impaired postnatal development of GABAergic synapses.  
 There is also evidence that mTOR binds to gephyrin (Sabatini et al., 1999), an important 
postsynaptic scaffolding protein at inhibitory synapses (Tyagarajan & Fritschy, 2014). A more 
recent study has shown that phosphorylation of gephyrin residue Ser200 is rapamycin-
sensitive (Demirkan et al., 2011). Moreover, rapamycin treatment of cultured hippocampal 
  P a g e  | 28 
neurons causes a reduction in the density of gephyrin clusters (Wuchter et al., 2012). 
Therefore, it is possible that impaired gephyrin clustering underlies the altered inhibitory 
synaptic input of raptor-depleted Purkinje cells. Furthermore, the mTORC2 downstream 
targets PKC and Akt phosphorylate the 2 subunit of GABAAR (McDonald & Moss, 1997; 
Wang et al., 2003) and Akt increases surface expression of GABAAR (Wang et al., 2003). 
Consequently, mTORC2 ablation may negatively affect the surface expression of GABAAR 
and hence lower inhibitory synaptic currents.  
 
Convergent phenotypes of sustained activation or inactivation of mTORC1 in Purkinje 
cells 
Another interesting aspect of our work is the rather similar phenotypes of RAPuKO and 
TSCPuKO mice although the immediate downstream signalling is the opposite. For example, 
both mouse models show a strong accumulation of neurofilaments in axonal swellings and a 
progressive loss of Purkinje cells due to apoptosis, which is paralleled by reactive gliosis. We 
also provide evidence that aberrant GSK3 signalling may underlie this convergence in the 
neurofilamentopathy as phosphorylation of GSK3 is strongly increased in lysates from raptor-
deficient brains and GSK3 signalling is also altered in mice deficient for TSC1 in the brain 
(Meikle et al., 2008). GSK3 phosphorylates neurofilaments at the E-segment (Sasaki et al., 
2002; Sasaki et al., 2009) and KSP repeats (Bajaj & Miller, 1997). While phosphorylation of 
KSP repeats is crucial for various functions including axonal transport (Shea et al., 2009; 
Holmgren et al., 2012), the E-segment has been suggested to affect the conformation of the C-
terminal KSP repeats (Sasaki et al., 2009). Thus, differential modification of the 
neurofilaments in the RAPuKO and TSCPuKO mice by GSK3 may result in a similar 
functional effect.  
 Besides the similarity in the neurodegenerative phenotype, RAPuKO and TSCPuKO 
mice also share behavioural similarities. Like in TSCPuKO mice (Tsai et al., 2012), the social 
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interest of RAPuKO mice was reduced at young age, when the Purkinje cell density was still 
unaffected. Alterations in inhibitory synaptic input and in dendritic morphology in the 
RAPuKO mice discussed above might underlie this abnormal social behaviour. A similar 
convergence of the phenotypes has been observed in mice deficient for raptor or TSC1 in 
skeletal muscle. In both cases the genetic manipulations result in myopathies that are 
characterized by vacuoles (Bentzinger et al., 2008; Castets et al., 2013). In skeletal muscle, 
changes in autophagy flux, although at different levels of the process, might underlie this 
convergence. In summary, our findings demonstrate that both, sustained activation and 
inhibition of mTORC1 in Purkinje cells, affect non-motor functions of the cerebellum and, at 
later time points, the survival of these neurons. Consequently, our data advice caution in 
treating brain disorders with rapamycin or other mTORC1 inhibitors, as has recently been 
suggested (Santini & Klann, 2011; Costa-Mattioli & Monteggia, 2013). 
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ABBREVIATIONS 
Akt/PKB, protein kinase B; Car8, carbonic anhydrase 8; CC3, cleaved caspase-3; CF, 
climbing fibre; EPSC, excitatory postsynaptic currents; FJB, Fluoro-Jade B; GABA, gamma-
aminobutyric acid; GABAAR, GABAA receptor; GAD65, glutamic acid decarboxylase 65 
kDa; GAP-43, growth associated protein 43; GCL, granule cell layer; GFAP, glial fibrillary 
acidic protein; GFP, green fluorescent protein; GSK3/, glycogen synthase kinase 3/; 
IPSC, inhibitory postsynaptic currents; LTD, long-term depression; LTP, long-term 
potentiation; MARCKS, myristoylated alanine-rich C-kinase substrate; mEPSC/mIPSC, 
miniature excitatory/inhibitory postsynaptic currents; mGluR1, metabotropic glutamate 
receptor 1; ML, molecular layer; mTOR, mammalian target of rapamycin; 
mTORC1/mTORC2, mammalian TOR complex 1/2; PF, parallel fibre; PI3K, 
phosphatidylinositol-3-kinase; PLC4, phospholipase C 4; PKC, protein kinase C; PPD, 
paired-pulse depression; PPF, paired-pulse facilitation; PTEN, phosphatase and tensin 
homolog; PC, Purkinje cell; RAbKO, raptor brain knockout; raptor, regulatory-associated 
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protein of mTOR; RAPuKO, raptor Purkinje cell knockout; rictor, rapamycin-insensitive 
companion of mTOR; RIPuKO, rictor Purkinje cell knockout; SGK1, serum-and 
glucocorticoid-induced protein kinase 1; (p)S6, (phosphorylated) ribosomal protein S6; 
TSC1/2, tuberous sclerosis complex 1/2; TSCPuKO, TSC1 Purkinje cell knockout. 
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TABLES 
 
  
mouse 
line 
1
st
 Ampl  
(in pA) 
2
nd
 Ampl  
(in pA) 
PPD/PPF 
(% of 1
st
 
Ampl) 
10-90% rise 
time  
(in ms) 
10-90% 
rise slope 
(in pA/ms) 
decay time 
constant 
(in ms) 
cells 
(n) 
                  
C
F-
EP
SC
 
Control 
RAPuKO 
-1275 ± 55 -871 ± 39 68 ± 1 0.67 ± 0.03 -1779 ± 128 19.6 ± 1.2 15 
RAPuKO 
-965 ± 42 
t31= 4.5 
P < 0.0001 
-565 ±23 
t31 = 7.1 
P < 0.0001 
59 ± 2 *** 
t31 = 4.5 
P < 0.0001 
0.77 ± 0.04 
t29 = 2.03 
P = 0.052 
-1131 ± 85 
t29 = 4.3 
P = 0.0002 
11.7 ± 0.5 
t31 = 6.4 
P = < 0.0001 
 
 
≥ 16 
 
 
                
Control 
RIPuKO 
-1150 ± 68 -790 ± 44 69 ± 2 0.66 ± 0.03 -1606 ± 116 18.9 ± 1.1 ≥ 10 
RIPuKO 
-944 ± 67 
t27 = 2.02 
P = 0.053 
-512 ± 37 
t27 = 4.7 
P < 0.0001 
55 ± 2 
t27 = 6.1 
P < 0.0001 
0.83 ± 0.06 
t23 = 2.3 
P = 0.031 
-1118 ± 126 
t23 = 2.7 
P = 0.014 
10.2 ± 0.6 
t26 =7.8 
P < 0.0001 
 
 
≥ 15 
 
 
          
P
F-
EP
SC
 
Control 
RIPuKO 
-229 ± 12 -317 ± 26 140 ± 8 2.32 ± 0.18 -91 ± 8 11.6 ± 0.7 6 
RIPuKO 
-266 ± 26 
t12 = 1.15 
P = 0.27 
-338 ± 47 
t12 = 0.35 
P = 0.73 
133 ± 2 
t12 = 1.1 
P = 0.29 
1.79 ± 0.05 
t12 = 3.2 
P = 0.007 
-138 ± 19 
t12 = 2.02 
P = 0.067 
8.7 ± 0.4 
t13 = 4.3 
P = 0.0009 
 
 
≥ 8 
 
 
 
Table 1: Kinetics and short-term plasticity of CF-EPSCs and PF-EPSCs. Average values 
± SEM are indicated. A two-tailed Student’s t-test was used to compare knockout mice with 
corresponding control mice.  
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RIPuKO RAPuKO 
B
eh
av
io
u
r Motor coordination Deficits already at young age Deficits only at high age 
Olfactory 
habituation 
/dishabituation 
Normal 
Interest in social odours 
reduced 
M
o
rp
h
o
lo
gy
 
Purkinje soma size Reduced by ~ 25%* Reduced by ~ 50% 
Dendritic tree 
~ 40% of PCs multiple primary 
dendrites (up to 4)* 
~ 40% of PCs multiple primary 
dendrites (up to 6) 
El
ec
tr
o
p
h
ys
io
lo
gy
 
Capacitance Reduced by ~ 30% Reduced by ~ 70% 
mEPSC Frequency reduced by ~ 50%* Normal 
mIPSC Amplitude reduced by ~ 15 %* Frequency reduced by ~ 80% 
Climbing fibre 
innervation 
~ 40% of PCs multiple CFs  Normal 
P
C
 s
u
rv
iv
al
 
Purkinje cell density Normal (analysed up to 90 wk)  Reduced in mice >11 wk 
Purkinje cell 
apoptosis 
no yes 
  
* see Thomanetz et al., 2013 
  
Table 2: Comparison of phenotypes of RIPuKO and RAPuKO mice. 
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FIGURE LEGENDS 
 
Figure 1: Behavioural assessment of RIPuKO and RAPuKO mice. A and B, Balance 
beam tests of RIPuKO (A) and RAPuKO (B) mice and their respective control littermates at 
different ages. The number of hind leg slips per meter was measured as a readout of ataxia. 
For each group n ≥ 8 mice were tested. C and D, Footprint pattern analysis of RIPuKO (C) 
and RAPuKO (D) mice and their control mice (n ≥ 7 mice for each group) of the indicated 
age. The steps of the hind and front paws are indicated in black and red, respectively. Hind 
limb gait width (W) was measured as indicated in (C). E and F, Olfactory 
habituation/dishabituation test with n ≥ 12 male RIPuKO (E) or RAPuKO (F) mice and 
corresponding control mice. Non-social and social odours were presented to the mice on a 
cotton swab in 2 and 3 repetitions as indicated. Bars represent mean ± SEM. Data of (A – D) 
were analysed by a two-tailed Student’s t-test and for (E – F) a two-way ANOVA, 
Bonferroni’s post hoc analysis was used. P-values: ** P < 0.01; * P < 0.05; ns P ≥ 0.05. Scale 
bar: 10 cm. 
 
Figure 2. Morphology of Purkinje cells is altered in RAPuKO mice. A, Sagittal cerebellar 
slices of 6-week-old RAPuKO mice and corresponding control mice were co-stained for 
calbindin (red) and pS6green. All calbindin-positive neurons are also pS6-positive (yellow) 
in control mice (left) whereas most Purkinje cells are pS6-negative in RAPuKO mice (right). 
B, Average soma area of Purkinje cells of control mice (black bars) and pS6-positive (yellow) 
or pS6-negative (red) Purkinje cells in RAPuKO mice of different age. Data represent 
Purkinje cell somata of lobes IV & V of n ≥ 3 mice for each time point and genotype. C, 
Purkinje cells of 4- to 6-week-old RAPuKO or control mice (n ≥ 8) were labelled with 
biocytin by the whole-cell patch clamp technique and detected by fluorescein (DTAF) 
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streptavidin after PFA fixation. Pictures in (C) represent the projection of 52 or 28 confocal 
optical sections (voxel size: 0.27 x 0.27 x 0.5 m) taken from a control or a RAPuKO mouse, 
respectively. D, Quantification of the number of primary dendrites originating from a Purkinje 
cell soma. E, Cerebellar slices of the mice described in (A) were co-stained for calbindin (red) 
and the mTORC2 downstream target PKCgreen. Purkinje cells of RAPuKO and control 
mice show similar levels of PKC. Bars represent mean ± SEM. Statistical analysis used one-
way ANOVA with Tukey’s post hoc analysis. P-values: *** P < 0.001; ** P < 0.01; ns P ≥ 
0.05. Scale bars: 200 m (A and E), 50 m (C). 
 
Figure 3. Inhibitory synaptic input is altered in raptor-knockout Purkinje cells. A, 
Sample traces of mEPSC recordings taken from Purkinje cells of 6-week-old control or 
RAPuKO mice. B and C, Quantification of mEPSC frequency (B) and amplitude (C) recorded 
from 5 RAPuKO (red) and 4 control (black) mice. Mean values and cumulative distributions 
of recordings from 12 raptor-deficient (red) and 14 control (black) Purkinje cells are shown. 
D, mIPSC sample traces of Purkinje cells of 6-week-old control or RAPuKO mice. E and F, 
Quantification of mIPSC frequency (E) and amplitude (F) recorded from 3 RAPuKO (red) 
and 3 control (black) mice. Mean values and cumulative distributions of recordings from 14 
raptor-deficient (red) and 16 control (black) Purkinje cells are shown. G, Sagittal cerebellar 
sections of 6-week-old RAPuKO or control mice stained with antibodies to the α1 subunit of 
GABAA receptors (red). Co-staining against Car8 (green) and pS6 (blue) was used to identify 
Purkinje cell somata and to confirm raptor deficiency, respectively. Each picture shows 
projections of 3 confocal optical sections (voxel size: 0.13 x 0.13 x 0.44 m). H, Staining of 
the molecular layer of the same mice used in (G) for GABAA α1 (red), GAD65 (green; stains 
GABAergic presynaptic terminals) and for pS6 (blue). Each picture shows projections of 3 
confocal optical sections (voxel size: 0.1 x 0.1 x 0.44 m). I and K, Analysis of the 
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perisomatic GABAA1 subunit clusters shown in (G). (I) shows the average number of 
GABAA1 subunit clusters at the soma of pS6-negative Purkinje cells (n ≥ 5 per mouse) of 
RAPuKO mice (n = 6) or Purkinje cells (n ≥ 10 per mouse) of control mice (n = 4). (K) shows 
the quantification of the GABAA1 subunit cluster size at these somata. J and L, 
Quantification of the mean density (J) or size (L) of the clusters positive for GAD65, for the 
GABAA1 subunit (α1) and for both (GAD65 + 1), detected in the molecular layer of 
control (black) or RAPuKO (red) mice (n ≥ 4 per genotype). Bars represent mean ± SEM. 
Data in B, C, E, F and I - L were analysed by a two-tailed Student’s t-test. P-values: *** P < 
0.001; ** P < 0.01; ns P ≥ 0.05. Scale bars: 10 m (G) and 20 m (H). 
 
Figure 4. Rictor-deficient Purkinje cells are innervated by multiple CFs, show 
impairment in dendritic self-avoidance but normal LTD. A - C, Paired current pulses in 
the granule cell layer were used to elicit CF-EPSC responses in Purkinje cells. Stimulation 
intensity was continuously increased and the size of the postsynaptic response was recorded. 
In control mice (A), the CF-EPSC response occurred in an “all or nothing” manner and did not 
change by further increasing the stimulation intensity, indicating mono CF innervation of the 
Purkinje cell. In 4-week-old RIPuKO (B) or 12-week-old RIPuKO mice (C), CF-EPSC 
responses revealed 2 or 3 discrete steps in response to increasing stimulation intensity, 
indicating multiple innervation by CFs. D, Percentage of the Purkinje cells showing the 
indicated number of discrete CF-EPSC steps of 4- or 12-week-old RIPuKO or corresponding 
control mice. The indicated numbers of Purkinje cells were analysed from n ≥ 4 mice for each 
genotype and age. E - G, Analysis of CF innervation of Purkinje cells of 4-week-old 
RAPuKO or control mice (n ≥ 4) using the same experimental approach as described in (A - 
D). H, Stimulation paradigm to elicit cerebellar LTD by repetitive stimulation of afferent PFs 
and simultaneous depolarization of the voltage-clamped Purkinje cell to 20 mV for 500 ms. I 
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and J, Sample traces of PF-EPSCs recorded in Purkinje cells of a 7-week-old control (I) or 
RIPuKO mouse (J) before and 30 minutes after LTD induction. K, Fold change of the PF-
EPSC amplitude monitored in 6 control and 11 rictor-deficient Purkinje cells over 40 minutes 
after LTD induction (n ≥ 3 individual mice of each genotype). There is no difference between 
control- and rictor-deficient neurons. L and M, Confocal microscopy pictures of spiny distal 
dendritic branches of biocytin-labelled Purkinje cells of 12-week-old control or RIPuKO 
mice. Acute slices containing the labelled cells were re-sliced and stained with Cy3-
streptdavidin (red) and an anti-PKC antibody (blue) to detect the labelled cells and to 
confirm mTORC2 ablation, respectively, as previously described (Thomanetz et al., 2013). 
Pictures represent projections of 81 or 93 confocal optical sections (voxel size: 0.07 x 0.07 x 
0.2 m) taken from a control or a RIPuKO mouse, respectively. The number of dendritic self-
crossings (white arrows) was counted. N, Relative number of dendritic self-crossings detected 
in RIPuKO mice expressed as percentage of dendritic self-crossings detected in control mice. 
n ≥ 30 Purkinje cells of RIPuKO or corresponding control mice (n = 4 for each genotype) 
were analysed. Data in (K and N) represent mean ± SEM and were analysed by a two-tailed 
Student’s t-test. P-values: *** P < 0.001. Scale bars: 25 m (L and M). 
 
Figure 5. Depletion of raptor, but not rictor causes age-dependent loss of Purkinje cells 
due to apoptosis. A, Sagittal cerebellar slices of 86-week-old RIPuKO mice and 
corresponding control mice were co-stained for calbindin (red) and PKCgreen to confirm 
mTORC2 ablation in Purkinje cells. Calbindin staining was used to determine Purkinje cell 
density in the cerebellar lobes IV & V of RIPuKO and control mice. B, Purkinje cell density 
determined for RIPuKO and corresponding control mice at different age. For each age and 
genotype, n ≥ 3 mice were analysed with n ≥ 3 cerebellar slices per mouse. C and D, Staining 
for calbindin (red) and pS6 (green) to analyse Purkinje cell density and mTORC1 ablation in 
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41-week-old RAPuKO and control mice. Purkinje cell density at different age was monitored 
as described in (A and B). E, Confocal pictures of an apoptotic Purkinje cell detected by co-
staining of cerebellar slices of an 11-week-old RAPuKO mouse using Hoechst and antibodies 
against calbindin and CC3. Each picture shows the projection of 19 optical confocal sections 
(voxel size: 0.1 x 0.1 x 0.46 m). F, The fraction of cerebellar slices containing the indicated 
numbers of CC3-positive Purkinje cells were determined for RAPuKO or control mice (n = 4 
mice per genotype). G, GFAP staining of a sagittal cerebellar slice of an 11-week-old 
RAPuKO or control mouse. Similar results were obtained with additional RAPuKO and 
control mice of the same age (n = 3 mice per genotype). The inset highlights increased GFAP 
expression in palisade-like structures in RAPuKO mice (white arrow). IV - X indicate the 
numbers of the cerebellar lobes. H, Cerebellar section of an 11-week-old RAPuKO mouse co-
stained against GFAP, PKC and mouse-IgG followed by confocal microscopy analysis 
(voxel size: 0.34 x 0.34 x 0.54 m). Projections of 25 confocal planes are shown. PKC labels 
Purkinje cells while mouse IgG stains blood vessels, which helps to differentiate between 
GFAP staining and blood vessels that are also seen in the insets of (G). Bars represent mean ± 
SEM. Data of (B, D and F) were analysed by a two-tailed Student’s t-test. P-values: *** P < 
0.001; ** P < 0.01; ns P ≥ 0.05. Scale bars: 200 m (A and C), 20 m (E), 1 mm (G), 100 m 
(inset of G), 50 m (H). PCL: Purkinje cell layer; ML: molecular layer; GCL: granule cell 
layer.  
 
Figure 6. Raptor-deficient Purkinje cells show dendritic degeneration and axonal 
swellings that accumulate neurofilaments. A, Example of Fluoro-Jade B (FJB) puncta seen 
in the molecular layer (white arrow) and in the Purkinje cell layer (yellow arrow) of RAPuKO 
mice. For quantification shown in (B), accumulation of FJB-positive puncta were counted as 
one FJB patch (encircled with the dashed, pink line). B, Fraction of cerebellar slices of 6- and 
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11-week-old RAPuKO or control mice (n = 3 for each age and genotype) that contain 0; 1-5; 
6-10 or > 10 FJB patches. C, Confocal picture of a biocytin-labelled Purkinje cell of a 6-
week-old RAPuKO mouse that shows signs of atrophy and beadings (white arrows), 
indicative of dendritic degeneration. Projection of 52 confocal optical sections is shown 
(voxel size: 0.27 x 0.27 x 0.2 m). D – G, Confocal pictures of sagittal cerebellar slices of 11-
week-old RAPuKO mice stained for calbindin and for neurofilament H (D), phosphorylated 
neurofilaments (SMI31) (E), cytochrome c (F), or synaptophysin (G). Axonal swellings 
(white arrows) contained neurofilament H and phosphorylated forms of neurofilaments 
(SMI31-positive) but were devoid of cytochrome c and synaptophysin. Projections of 33 – 84 
confocal optical sections are shown (voxel size: 0.11 x 0.11 x 0.2 m). H, Relative proportion 
of cerebellar sections of 6- and 11-week-old RAPuKO or control mice (n = 4 mice per age 
and genotype) that reveal 0; 1-5 or > 5 axonal swellings proximal to the Purkinje cell somata 
as shown in (D - G). I, Western blot analysis of total brain lysates derived from embryonic 
day 19.5 mice depleted of raptor as previously described (Cloetta et al., 2013). Lysates were 
probed with a phospho-specific antibody recognizing P-Ser21 on GSK3 and P-Ser9 on 
GSK3 and antibodies recognizing the total protein. Antibodies to -tubulin were used as 
loading control. J, Quantification of Western blot signals shown in (I) relative to the 
intensities in control mice (n = 5 per genotype). Bars represent mean ± SEM. Data in (B, H 
and J) were analysed by a two-tailed Student’s t-test. P-values: *** P < 0.001; ** P < 0.01; * 
P < 0.05; ns P ≥ 0.05. Scale bars: 100 m (A), 50 m (C) and 25 m (D – G). PCL: Purkinje 
cell layer; ML: molecular layer; GCL: granule cell layer. 
 
Figure 7. Depletion of TSC1 in Purkinje cells results in the accumulation of 
neurofilaments in axons and in reactive gliosis. A and B, Sagittal cerebellar slices of 11-
week-old TSCPuKO mice were stained with anti-calbindin and anti-neurofilament H (A) or 
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SMI31 antibodies (B). Like in RAPuKO mice, axonal swellings (white arrows) that are 
positive for neurofilament H and phosphorylated neurofilaments (SMI31-positive) are 
detected in TSC1-deficient Purkinje cells. Pictures show projections of 100 (A) or 82 (B) 
confocal optical sections (voxel size: 0.27 x 0.27 x 0.2 m). C, Sagittal cerebellar slices of 11-
week-old TSCPuKO or control mice stained for GFAP. The white arrow indicates reactive 
gliosis that manifests as palisade-like, GFAP-positive structures in the molecular layer of 
TSCPuKO but not control mice (n = 3 mice per genotype). Scale bars: 50 m (A and B), 1 
mm (C), 100 m (inset of C). PCL: Purkinje cell layer; ML: molecular layer; GCL: granule 
cell layer. I to VIII designate numbers of the cerebellar lobes. 







 Supporting figure 1. Validation of pS6 as marker for raptor depletion in Purkinje cells. 
A, Sagittal cerebellar slices of 11-week-old RAPuKO GFP mice were co-stained for the 
Purkinje cell marker calbindin (red), the GFP reporter (green) and pS6 (blue). The insert 
shows a representative sample of the different populations of Purkinje cells; somata are 
encircled in white. B, Percentage of Purkinje cells expressing the different markers. Cells that 
underwent Cre-mediated recombination are GFP-positive and negative for pS6 [GFP(+)/pS6(-
)]. Cells that never expressed Cre are GFP-negative and pS6-positive [GFP(-)/pS6(+)]. Less 
than 11% of the cells express GFP and are pS6-positive [GFP(+)/pS6(+)] or are double 
negative [GFP(-)/pS6(-)]. Purkinje cells of cerebellar lobes IV & V of 3 RAPuKO GFP mice 
were used for quantification. C, Soma size of the Purkinje cells expressing the different 
markers relative to the soma size of GFP(-)/pS6(+) cells. Bars represent mean ± SEM for n = 
3 mice. Statistical analysis used one-way ANOVA with Tukey’s post hoc analysis. P-values: 
*** P < 0.001; ns P ≥ 0.05. Scale bars: 200 µm (A), 100 µm (inset of A). 
 
 Supporting figure 2. Passive properties of rictor- and raptor-deficient Purkinje cells. A 
and B, Fluorescence micrographs of biocytin-labelled Purkinje cells of 6-week-old RAPuKO 
mice that were detected by Cy3-streptavidin and co-stained for pS6. (A) pS6-negative and 
hence raptor-deficient Purkinje cell. (B) pS6-positive Purkinje cell. Note that this cell is 
bigger than that shown in (A). Pictures of (A) and (B) represent the projection of 122 or 86 
confocal optical sections (voxel size: 0.38 x 0.38 x 0.5 µm), respectively. C, Soma size of 
recorded Purkinje cells of control and RAPuKO mice. Projections of confocal sections of 
biocytin-labelled Purkinje cells as shown in (A and B) were used for quantification. D and E, 
Capacitance (D) and membrane resistance (E) of Purkinje cells of 6-week-old RIPuKO, 
RAPuKO or corresponding control mice. n ≥ 9 Purkinje cells of n ≥ 3 mice were analysed for 
each genotype. Bars represent mean ± SEM. A two-tailed Student’s t-test or a one-way 
ANOVA with Tukey’s post hoc analysis was used for statistical analysis of RIPuKO or 
RAPuKO mice, respectively, in (C - E). P-values: *** P < 0.001; ns P ≥ 0.05. Scale bars: 100 
µm (A and B), 50 µm (insets of A and B). 
 
